TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20385971

Group type: EXPERIMENTAL
Intervention: Olmesartan medoxomil (low-dose: 2.5 or 5 mg; high-dose: 20 or 40 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Olmesartan medoxomil (continued therapy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (washout)
Number of subjects: 0
Study: 18359175

Group type: EXPERIMENTAL
Intervention: 2mg oral micronized estradiol (E2) (n=25)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: 2mg oral E2 + 1mg oral norethisterone acetate (NETA) (n=28)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo (n=24)
Number of subjects: 77
Study: 16093400

Group type: EXPERIMENTAL
Intervention: Yam (Dioscorea alata) 390 g in 2 of 3 meals per day for 30 days
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sweet potato 240 g for 41 days (control)
Number of subjects: 24
Study: 12506292

Group type: EXPERIMENTAL
Intervention: Laparoscopic technique (LT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Open technique (OT)
Number of subjects: 60
Study: 10099888

Group type: EXPERIMENTAL
Intervention: Immunomodulating bacterial extract (IBE)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 40
Study: 8672605

Group type: EXPERIMENTAL
Intervention: Ipsapirone (0.5 mg/kg orally)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Ipsapirone
Number of subjects: 32
Study: 2216186

Group type: EXPERIMENTAL
Intervention: Wound reclosure by a standardized en bloc technique (35 patients)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Healing by second intention (6 patients)
Number of subjects: 41
Study: 387492

Group type: EXPERIMENTAL
Intervention: Finorgal (ethchlorvynol with diphenhydramine)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 31978543

Group type: EXPERIMENTAL
Intervention: Natural music stimuli (unedited songs)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Measure-shuffled versions of music
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Frequency-domain measures of correlation (coherence)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Phase-scrambled controls
Number of subjects: 48
Study: 31317511

Group type: EXPERIMENTAL
Intervention: Adherence-contingent rebates
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care (no rebates)
Number of subjects: 100
Study: 28350753

Group type: EXPERIMENTAL
Intervention: High-calorie dinners (British, German, Italian with alcohol)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Low-fat, low-calorie Czech dinner
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: High-fat, high-calorie British dinner
Number of subjects: 84

Group type: COMPARATOR
Intervention: Low-fat meals
Number of subjects: 84
Study: 25264014

Group type: EXPERIMENTAL
Intervention: Kinesiology taping with 35-40% stretch
Number of subjects: 14

Group type: COMPARATOR
Intervention: Kinesiology taping without stretch
Number of subjects: 14
Study: 23514765

Group type: EXPERIMENTAL
Intervention: Whole-grain and fiber-rich rye breads
Number of subjects: 51

Group type: COMPARATOR
Intervention: Refined wheat breads
Number of subjects: 51
Study: 21474481

Group type: EXPERIMENTAL
Intervention: Sidecar crib
Number of subjects: 1204

Group type: COMPARATOR
Intervention: Standalone cot
Number of subjects: 1204
Study: 19622121

Group type: EXPERIMENTAL
Intervention: Combined betamethasone dipropionate and calcipotriol
Number of subjects: 30

Group type: COMPARATOR
Intervention: Betamethasone dipropionate
Number of subjects: 30

Group type: COMPARATOR
Intervention: Calcipotriol
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combined therapy (betamethasone dipropionate and calcipotriol)
Number of subjects: 30
Study: 16920219

Group type: EXPERIMENTAL
Intervention: Drain removal at 24 hours
Number of subjects: 0

Group type: COMPARATOR
Intervention: Drain removal at 72 hours
Number of subjects: 0
Study: 12872081

Group type: EXPERIMENTAL
Intervention: Suck-and-ligate device without prior submucosa injection
Number of subjects: 72

Group type: COMPARATOR
Intervention: Cap technique with prior submucosa injection of dilute saline solution of epinephrine
Number of subjects: 72
Study: 8731701

Group type: EXPERIMENTAL
Intervention: Nonsteroidal antiinflammatory drugs (NSAIDs)
Number of subjects: 0
Study: 1525801

Group type: EXPERIMENTAL
Intervention: Sodium valproate (500 mg, single oral dose)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (in 4 migraine patients)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Healthy controls (n=5)
Number of subjects: 10
Study: 3902675

Group type: EXPERIMENTAL
Intervention: KB-944 100 mg/day
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: KB-944 200 mg/day
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 30187284

Group type: EXPERIMENTAL
Intervention: Sodium selenite (SS) 400 μg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Se-methylselenocysteine (MSC) 400 μg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Seleno-l-methionine (SLM) 400 μg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 24
Study: 28853492

Group type: EXPERIMENTAL
Intervention: Topical aprepitant
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo vehicle
Number of subjects: 0
Study: 26354741

Group type: EXPERIMENTAL
Intervention: Open pleurae, collapsed lungs and conventional pulmonary perfusion and ventilation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intact pleurae, expanded lungs and gradual pulmonary perfusion and ventilation
Number of subjects: 20
Study: 24176927

Group type: EXPERIMENTAL
Intervention: Anodal tDCS combined with computer-assisted cognitive training
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham tDCS combined with computer-assisted cognitive training
Number of subjects: 40
Study: 22129066

Group type: EXPERIMENTAL
Intervention: Neuropattern diagnostics provided to physicians (experimental group, n=51)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Usual treatment without NP diagnostics (control group, n=50)
Number of subjects: 101
Study: 20471248

Group type: EXPERIMENTAL
Intervention: Pemetrexed/carboplatin
Number of subjects: 402

Group type: COMPARATOR
Intervention: Gemcitabine/carboplatin
Number of subjects: 402
Study: 17505919

Group type: EXPERIMENTAL
Intervention: HAART along with syphilis and herpes simplex virus type 2 (HSV-2) treatment
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Increasing condom use
Number of subjects: 350
Study: 15661440

Group type: EXPERIMENTAL
Intervention: Intervention (fear reducing and activating techniques)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control
Number of subjects: 240
Study: 11940726

Group type: EXPERIMENTAL
Intervention: Alendronate 10 mg/d fasting before breakfast
Number of subjects: 80

Group type: COMPARATOR
Intervention: Alendronate 10 mg/d fasting at noon before lunch
Number of subjects: 80
Study: 10655440

Group type: EXPERIMENTAL
Intervention: Reminder telephone call
Number of subjects: 1765

Group type: EXPERIMENTAL
Intervention: Motivational telephone call addressing barriers
Number of subjects: 1765

Group type: COMPARATOR
Intervention: Reminder post‐card
Number of subjects: 1765

Group type: EXPERIMENTAL
Intervention: Prior mammography
Number of subjects: 1765
Study: 8880611

Group type: EXPERIMENTAL
Intervention: Experimental diet (EN-9305)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control diet (Osmolyte HN)
Number of subjects: 20
Study: 1947851

Group type: EXPERIMENTAL
Intervention: ESWL treatment by experienced surgeons (group A)
Number of subjects: 89

Group type: COMPARATOR
Intervention: ESWL treatment by inexperienced surgeons (group B)
Number of subjects: 89
Study: 6716324

Group type: EXPERIMENTAL
Intervention: Systematic clinical assessment during admission and a few weeks after return home
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Multiple regression analysis of information obtained during the acute hospital admission
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Early findings
Number of subjects: 229
Study: 31365044

Group type: EXPERIMENTAL
Intervention: Estradiol patch (200-μg)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 200
Study: 27658997

Group type: EXPERIMENTAL
Intervention: NuStat® hemostatic dressing
Number of subjects: 20

Group type: COMPARATOR
Intervention: Historic standard of care
Number of subjects: 20
Study: 24149761

Group type: EXPERIMENTAL
Intervention: Plyometric training with 24 hours of rest (PT24)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Plyometric training with 48 hours of rest (PT48)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 166
Study: 23200084

Group type: EXPERIMENTAL
Intervention: Paroxetine (20 mg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Bupropion (150 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 21541727

Group type: EXPERIMENTAL
Intervention: Children with PKU
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Higher lifetime Phe levels
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Higher lifetime Phe levels and Index of Dietary Control (IDC)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Quality of dietary control
Number of subjects: 64
Study: 18201203

Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Rosiglitazone 8 mg
Number of subjects: 273

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 273
Study: 16549261

Group type: EXPERIMENTAL
Intervention: Antibiotics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standardized Alzheimer's Disease Assessment Scale cognitive subscale
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pooled index of six outcome measures
Number of subjects: 0

Group type: COMPARATOR
Intervention: Individual measures
Number of subjects: 0
Study: 15642722

Group type: EXPERIMENTAL
Intervention: Red wine (150 ml, 15 g alcohol)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Abstention from alcohol
Number of subjects: 87
Study: 10979918

Group type: EXPERIMENTAL
Intervention: Albendazole (2 sequential doses of 400 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9295004

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol-17beta (100 mg/day)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 16
Study: 8333745

Group type: EXPERIMENTAL
Intervention: Postoperative chemotherapy (CDDP 50 mg/m2 + VDS 3 mg/m2)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Postoperative radiotherapy (30 Gray)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Postoperative chemotherapy (CDDP + VDS)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 30
Study: 2883273

Group type: EXPERIMENTAL
Intervention: Terazosin
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 2722305

Group type: EXPERIMENTAL
Intervention: Hypnotic induction and suggestions derived from Rational‐Emotive Therapy, 4 weekly treatment sessions
Number of subjects: 40

Group type: COMPARATOR
Intervention: Discussion of stress reduction methods (Control)
Number of subjects: 40
Study: 29514344

Group type: EXPERIMENTAL
Intervention: mCare (standard care management plus mCare)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Standard care management alone (control)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: mCare
Number of subjects: 182

Group type: COMPARATOR
Intervention: Standard care management
Number of subjects: 182
Study: 28636208

Group type: COMPARATOR
Intervention: PRN1008 (50-1200 mg single dose)
Number of subjects: 6

Group type: COMPARATOR
Intervention: PRN1008 (300-900 mg daily for 10 days)
Number of subjects: 6

Group type: COMPARATOR
Intervention: PRN1008 (single and multiple doses)
Number of subjects: 6
Study: 26142048

Group type: EXPERIMENTAL
Intervention: H pylori vaccine
Number of subjects: 4464

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4464
Study: 24170762

Group type: EXPERIMENTAL
Intervention: Dietary fiber (quartiles from 8.7 to 21.8 g)
Number of subjects: 1414

Group type: EXPERIMENTAL
Intervention: Vegetables and fruits (quartiles from 228.7 to 721.4 g)
Number of subjects: 1414

Group type: EXPERIMENTAL
Intervention: Soluble dietary fiber (per 1-g increase)
Number of subjects: 1414

Group type: EXPERIMENTAL
Intervention: Total dietary fiber (per 1-g increase)
Number of subjects: 1414

Group type: EXPERIMENTAL
Intervention: Insoluble dietary fiber (per 1-g increase)
Number of subjects: 1414
Study: 21939839

Group type: EXPERIMENTAL
Intervention: Canrenone
Number of subjects: 146

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 146
Study: 18335698

Group type: EXPERIMENTAL
Intervention: EpiCor (500 mg daily)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study: 16584855

Group type: COMPARATOR
Intervention: Seretide Diskus (salmeterol xinafoate 50 mcg; fluticasone propionate 500 mcg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Symbicort Turbuhaler (formoterol 6 mcg; budesonide 200 mcg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Symbicort Turbuhaler
Number of subjects: 20
Study: 14977304

Group type: EXPERIMENTAL
Intervention: 5.25% sodium hypochlorite (NaOCl) without prior immersion of contaminated files (Group I)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 5.25% sodium hypochlorite (NaOCl) with prior immersion of contaminated files for 10 seconds (Group II)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sterile files (Negative Control Group)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Contaminated patency files in teeth with empty canals (First Positive Control Group)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Contaminated files placed into broth next to teeth filled with NaOCl (Second Positive Control Group)
Number of subjects: 28
Study: 11688199

Group type: EXPERIMENTAL
Intervention: Automated telephone reminder
Number of subjects: 2304

Group type: EXPERIMENTAL
Intervention: Postcard reminder
Number of subjects: 2304

Group type: COMPARATOR
Intervention: No reminder
Number of subjects: 2304
Study: 9106854

Group type: EXPERIMENTAL
Intervention: Sentence Reading Condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Word Reading Condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Syllable Reading Condition
Number of subjects: 0
Study: 7684351

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (subcutaneous injection, single fixed daily dose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard heparin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral anticoagulants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dextron
Number of subjects: 0
Study: 3544755

Group type: EXPERIMENTAL
Intervention: Nitroprusside at an initial rate of 1.3 micrograms/kg/min
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Nifedipine at an initial rate of 0.7 micrograms/kg/min
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control measurements obtained 10 minutes after intubation
Number of subjects: 20
Study: 29572400

Group type: EXPERIMENTAL
Intervention: Usual care plus supported self-management delivered by community palliative care nurses
Number of subjects: 160

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Usual care plus supported self-management
Number of subjects: 160
Study: 26608839

Group type: EXPERIMENTAL
Intervention: Tourniquet application for 60 minutes
Number of subjects: 10

Group type: COMPARATOR
Intervention: Non-tourniquet group
Number of subjects: 10
Study: 24522170

Group type: EXPERIMENTAL
Intervention: Once-daily insulin detemir (initiated with mean 0.12 U/kg)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Twice-daily insulin detemir (initiated with mean 0.12 U/kg)
Number of subjects: 50
Study: 19828278

Group type: EXPERIMENTAL
Intervention: Routine HIV testing program in the emergency department (ED)
Number of subjects: 108
Study: 20142027

Group type: EXPERIMENTAL
Intervention: Self-assessed NYHA class (SA-NYHA)
Number of subjects: 293
Study: 18678159

Group type: EXPERIMENTAL
Intervention: Yan three needling group (EA at three acupoints of eye: Jingming, Shangming, Chengqi)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Routine acupuncture group (EA at routinely selected acupoints: Yifeng, Dicang, etc.)
Number of subjects: 76
Study: 15976218

Group type: EXPERIMENTAL
Intervention: Remifentanil (Ce50 5.0 ng/mL) during tracheal intubation (group TI, n = 20)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Remifentanil (Ce50 2.1 ng/mL) during skin incision (group SI, n = 21)
Number of subjects: 41
Study: 12804052

Group type: COMPARATOR
Intervention: Zevalin (ibritumomab tiuxetan) regimen including 5 mCi (111)In-labeled Zevalin on Day 1 and 0.4 mCi/kg (90)Y Zevalin on Day 8, preceded by 250 mg/m(2) rituximab.
Number of subjects: 143

Group type: COMPARATOR
Intervention: Zevalin (ibritumomab tiuxetan) regimen
Number of subjects: 143
Study: 11085661

Group type: EXPERIMENTAL
Intervention: Allergic skin diseases (55%)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Infections (33%)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Photodermatosis (8%)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Atopic dermatitis (47% of allergic skin diseases)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Seborrheic dermatitis (17.4% of allergic skin diseases)
Number of subjects: 1000
Study: 9069482

Group type: EXPERIMENTAL
Intervention: Patients with epilepsy during childhood
Number of subjects: 81

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 81
Study: 8347333

Group type: EXPERIMENTAL
Intervention: Physostigmine 2 mg q2h while awake for 7 days plus yohimbine 10 mg and 20 mg challenges
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo q2h while awake for 5 days plus yohimbine 10 mg and 20 mg challenges
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Physostigmine plus yohimbine
Number of subjects: 10
Study: 3087298

Group type: EXPERIMENTAL
Intervention: Regimen A (calcium intake: 0.55 mmol/kg/day, phosphate intake: 0.44 mmol/kg/day)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Regimen B (calcium intake: 1.08 mmol/kg/day, phosphate intake: 0.89 mmol/kg/day)
Number of subjects: 15
Study: 31425538

Group type: EXPERIMENTAL
Intervention: Multidisciplinary end-of-life educational intervention program (two educational workshops and an educational booklet)
Number of subjects: 291

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 291
Study: 28080097

Group type: EXPERIMENTAL
Intervention: Observers judging beginner English speakers
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Observers judging nonnative English speakers
Number of subjects: 56
Study: 26501147

Group type: EXPERIMENTAL
Intervention: Aliskiren 150‐300 mg/d
Number of subjects: 20

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (HCTZ) 12.5 ‐ 25 mg/d
Number of subjects: 20
Study: 23240681

Group type: EXPERIMENTAL
Intervention: Energy-dense food enrichment (+1673 kJ day⁻¹)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 41
Study: 21870978

Group type: EXPERIMENTAL
Intervention: Apixaban (5 mg twice daily)
Number of subjects: 18201

Group type: COMPARATOR
Intervention: Warfarin (target INR 2.0 to 3.0)
Number of subjects: 18201
Study: 19176401

Group type: EXPERIMENTAL
Intervention: Ghrelin (GHR)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Peptide YY (PYY)
Number of subjects: 7
Study: 17089021

Group type: EXPERIMENTAL
Intervention: SPS (600 mg daily)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 15591711

Group type: EXPERIMENTAL
Intervention: Trofosfamide 90 mg/m2
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Trofosfamide 125 mg/m2
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Trofosfamide 175 mg/m2
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Trofosfamide (all doses)
Number of subjects: 16
Study: 11494446

Group type: EXPERIMENTAL
Intervention: Manual therapy (MT) and point massage (PM)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Manual therapy (MT), point massage (PM), and bioresonance therapy (BRT)
Number of subjects: 60
Study: 10024190

Group type: EXPERIMENTAL
Intervention: Men >69.75 inches
Number of subjects: 6567

Group type: EXPERIMENTAL
Intervention: Tallest men
Number of subjects: 6567

Group type: COMPARATOR
Intervention: Women
Number of subjects: 6567
Study: 7799388

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 3279083

Group type: EXPERIMENTAL
Intervention: Naftifine cream 1%
Number of subjects: 104

Group type: COMPARATOR
Intervention: Econazole cream 1%
Number of subjects: 104
Study: 29742708

Group type: EXPERIMENTAL
Intervention: Mokhuri treatment program (Chuna, acupuncture, patient education)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional nonsurgical treatments (drugs for pain relief, epidural steroid injections, physical therapy)
Number of subjects: 0
Study: 27465912

Group type: EXPERIMENTAL
Intervention: Elcatonin (20 units, weekly intramuscular injections)
Number of subjects: 228

Group type: COMPARATOR
Intervention: NSAIDs (oral nonsteroidal anti-inflammatory drugs)
Number of subjects: 228
Study: 26711765

Group type: EXPERIMENTAL
Intervention: Clarithromycin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Doxycycline or Josamycin
Number of subjects: 40
Study: 24195205

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (specific points: Sishenzhen, Zhisanzhen, Niesanzhen, Naosanzhan) for 4 months
Number of subjects: 60

Group type: COMPARATOR
Intervention: Medication group (piracetam tablets) for 4 months
Number of subjects: 60

Group type: COMPARATOR
Intervention: Comparison between acupuncture and medication groups
Number of subjects: 60
Study: 21518561

Group type: EXPERIMENTAL
Intervention: Guideline for the appropriate use of antibiotics in CABG during the perioperative period
Number of subjects: 614

Group type: COMPARATOR
Intervention: Prophylactic antibiotic use
Number of subjects: 614
Study: 19863184

Group type: EXPERIMENTAL
Intervention: OXY-SCORE
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Plasma malondialdehyde (MDA)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Cardiopulmonary bypass (CPB)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Off-pump procedure (OPCAB)
Number of subjects: 47
Study: 16961161

Group type: EXPERIMENTAL
Intervention: 200 mg ketoconazole once daily on Days 1 - 4 and 5 mg SPP301 on Day 3
Number of subjects: 12

Group type: COMPARATOR
Intervention: 5 mg SPP301 administered alone
Number of subjects: 12
Study: 15093636

Group type: EXPERIMENTAL
Intervention: Surodex dexamethasone anterior segment drug delivery system
Number of subjects: 19

Group type: COMPARATOR
Intervention: Dexamethasone 0.1% eyedrops (Maxidex)
Number of subjects: 19